Systemic lupus erythematosus: safe and effective management in primary care.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 21050957.
- Also identified by DOI 10.1016/j.pop.2010.07.006.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Systemic lupus erythematosus is an autoimmune inflammatory disorder that frequently affects women of childbearing age. A diagnosis is made by confirming the presence of at least 4 of 11 criteria proposed by the American College of Rheumatology. Almost all patients should take hydroxychloroquine and most require corticosteroids, with immunosuppressive drugs frequently given as well. With better management, patients with lupus live longer but are at increased risk of disease and treatment-related complications, including infection, cardiovascular disease, and osteoporosis. These problems should be monitored and treated in the primary care setting.
Medical subject headings
- Lupus Erythematosus, Systemic
- Primary Health Care